Testosterone bolsters insulin sensitivity in men with diabetes

05/6/2013 | MedPage Today (free registration)

Testosterone replacement therapy fared better than placebo in boosting insulin sensitivity in men with type 2 diabetes and hypogonadotropic hypogonadism, a study presented at the American Association of Clinical Endocrinologists annual meeting revealed. Researchers also found those who underwent testosterone treatment showed better lean mass, total fat, C-reactive protein and free fatty acids compared with those in the placebo group.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ